The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
31
No.
16
April 22, 2005Apr 22, 2005
Free
DOWNLOAD THE PDF

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

Paulette Gray named director of NCI Division of Extramural Activities.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account